Health & Biotech PharmAust’s upcoming Phase 1 clinical trials receive major boost with the production of smaller tablets December 1, 2021 Special Report: The successful demonstration batch of smaller monepantel tablets has given PharmAust the confidence to manufacture the GMP version,… ASX Health Stocks: Rhythm Biosciences scores CE Mark approval, shares jump November 30, 2021 Cancer diagnostics company Rhythm Biosciences said CE Mark approval is now complete for its ColoSTAT blood test platform. As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments? November 30, 2021 One of the few bright spots in ASX Covid news in the past week, amidst the emergence of the Omicron… Here are the ASX heart stocks fighting the number one killer disease in humans November 30, 2021 Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year according to the WHO.… ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app November 29, 2021 The ASX 200 Health Index (XHJ) is down by 0.15% at the time of writing, compared to the broader index… Dr Boreham’s Crucible: Is Paul Hopper’s star power enough to get Radiopharm Theranostics beaming? November 29, 2021 He’s baaack! Fresh from founding and listing immune-oncology play Chimeric, Paul Hopper can add Radiopharm Theranostics (ASX:RAD) to his boardroom… ScoPo’s Powerplays: Christmas rally runs out of puff, but market awaits crucial release from Neuren November 26, 2021 Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains… ASX Health Stocks: Health app MedAdvisor maintains guidance, but share price slips 5pc November 26, 2021 The ASX 200 Health Index (XHJ) is down by 0.70% at the time of writing, compared to the broader index… ‘Untap significant earnings growth’: Equity firm says EZZ Life Science stock is undervalued November 26, 2021 Special Report: Equity firm ASR Wealth has outlined several growth opportunities for EZZ Life Science Holdings as it continues its… The Sustainable Nutrition Group’s MD Neale Joseph eyes slice of the $10.8 billion plant-based protein market pie November 26, 2021 The company has teamed up with Australian Plant Proteins to develop hemp concentrate and isolates, with commercialisation planned for 2022. Next» « Previous